Sorrento Therapeutics, Inc. Expected to Earn Q1 2021 Earnings of ($0.11) Per Share (NASDAQ ...

Retrieved on: 2021-02-01 06:11:15

Tags for this article:

Click the tags to see associated articles and topics

Sorrento Therapeutics, Inc. Expected to Earn Q1 2021 Earnings of ($0.11) Per Share (NASDAQ .... View article details on hiswai:

Excerpt

AQR Capital Management LLC now owns 37,589 shares of the biopharmaceutical company's stock valued at $236,000 after purchasing an additional ...

Article found on: www.marketbeat.com